COYA
Coya Therapeutics, Inc.
There isn't enough reported data to score COYA yet.
COYA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Weak | |
| Weak | |
| Unavailable |
COYA's revenue is currently stable, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
COYA PE Valuation
COYA has no meaningful PE right now: it lost money over the past year.
COYA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses steady | |
| Strong growth | |
| -- | |
| Limited | |
| Moderate |
Analysts expect COYA's revenue to grow, with its earnings and profitability holding steady.
COYA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$1.39 | -$0.28 |
| Q2 2026 | -$1.07 | +$0.17 |
| Q1 2026 | -$1.15 | -$0.08 |
| Q4 2025 | -$1.27 | -$0.29 |
| Q3 2025 | -$1.11 | -$0.45 |
| Q2 2025 | -$1.24 | -$0.50 |
| Q1 2025 | -$1.07 | -$0.21 |
| Q4 2024 | -$0.98 | -$0.19 |
COYA is still losing money, but less than at its worst: $1.39 per share over the past year, against $1.64 at its worst in early 2023.
COYA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $234.1K | -93% |
| Q2 2026 | $243.7K | +49% |
| Q1 2026 | $251.1K | -2.6% |
| Q4 2025 | $4M | +202769% |
| Q2 2025 | $163.6K | -95% |
| Q1 2025 | $257.9K | +103% |
COYA's revenue is growing: $234,134 last quarter, down 93% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -4676% | -4608 points |
| Q2 2026 | -2891% | +1029 points |
| Q1 2026 | -3042% | -65 points |
| Q4 2025 | -152% | +208879 points |
| Q3 2025 | -68% | N/A |
| Q2 2025 | -3920% | -3826 points |
| Q1 2025 | -2977% | +1346 points |
| Q4 2024 | -209032% | N/A |
COYA's operating margin was −4676% last quarter, down 4608 points from the same quarter a year ago, near the bottom of its range since 2024.
COYA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$7.2M | -$6.1M |
| Q2 2026 | -$7.4M | -$1.6M |
| Q1 2026 | -$6.2M | -$3.4M |
| Q4 2025 | -$1M | +$1.4M |
| Q3 2025 | -$1.1M | +$4.3M |
| Q2 2025 | -$5.8M | -$1.2M |
| Q1 2025 | -$2.8M | -232% |
| Q4 2024 | -$2.4M | -$168.7K |
COYA has burned cash in almost every quarter: −$22M over the past year, against −$12M the year before.
COYA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | +622 shares |
| 1 year | +40% | +6.7M shares |
| 3 years | +141% | +13.7M shares |
| 5 years | +806% | +20.9M shares |
COYA has 23M diluted shares, up 40% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | — |
| Q1 2022 | — |
| Q4 2021 | — |
| Q3 2021 | — |
| Q2 2021 | — |
| Q1 2021 | — |
COYA Net Leverage
COYA's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
COYA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.9 | Neutral |
| Stochastic | 10.7 | Oversold |
COYA's weekly RSI is 37 (neutral) and its Stochastic is 11 (oversold).
COYA PE vs Healthcare Sector
COYA has no meaningful PE right now: it lost money over the past year.
COYA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $4.11 | 20% below |
| 20 week MA | $4.50 | 27% below |
| 50 week MA | $4.67 | 30% below |
| 100 week MA | $5.37 | 39% below |
| 200 week MA | $5.69 | 43% below |
COYA is in a downtrend: it's below all five of its weekly moving averages, and 43% below its 200-week average.
COYA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2023 | $4.74 | $7.41 | +56% |
| 2024 | $7.41 | $5.92 | -20% |
| 2025 | $5.92 | $5.47 | -7.6% |
| 2026 YTD | $5.47 | $3.27 | -40% |
COYA has finished lower in two of the last three years. It's down 40% so far in 2026.